Europe Wearable Cardioverter Defibrillator Market By Conditions (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias)
Europe Wearable Cardioverter Defibrillator Market size was around USD XX billion in 2017. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2022.
Wearable cardioverter defibrillator is a gadget that is non-invasive it is utilized to prevent sudden heart attack. It has two parts: A light weight jacket which is worn under regular clothes and a small mobile unit which includes recorder and generator.
Sudden heart attack occurs when the heart's electrical system malfunctions. It directs the heart to relax and contract.
Those conditions where there is abnormal rhythm in the ventricles of the heart is known as Ventricular Fibrillation. When VF occurs, a WCD sends an electrical current to the heart that is used to revive a normal heart rhythm.
Defibrillators are used for the treatment of life-threatening ventricular fibrillation, heart dysrhythmias, and ventricular tachycardia.
Rising prevalence of diseases, increasing geriatric population, growing number of training and awareness among the population base and, technological advancements are the primary drivers of the market.On the other hand, factors like problems related to the use of wearable cardioverter defibrillator devices, inadequate knowledge regarding sudden cardiac arrest, and the wearable cardioverter defibrillator does not monitor atrial arrhythmias thus this hinders the growth of the market.
Europe Wearable Cardioverter Defibrillator Market Segmentation by Conditions and by End User. By Conditions it is segmented into Peripartum Cardiomyopathy, Congenital Heart Disease, and Inherited Arrhythmias.
By End User the market is segmented into Hospitals, Home Care Settings, and Cardiology Clinics.Europe Wearable Cardioverter Defibrillator Market geographical segmentation by UK, Spain, Germany, France and others. Europe is the second largest market.
Congenital Heart Disease
Home Care Settings
The major Europe Wearable Cardioverter Defibrillator Market leaders are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc.
(U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co.
KG (Germany), and Nihon Kohden Corporation (Japan)
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!